Literature DB >> 19116304

Acute parvovirus B19 infection frequently causes false-positive results in Epstein-Barr virus- and herpes simplex virus-specific immunoglobulin M determinations done on the Liaison platform.

Mario Berth1, Eugene Bosmans.   

Abstract

During an outbreak of parvovirus B19 we collected serum samples from 68 nonpregnant patients in the region of Antwerp (Belgium). Fifty-seven (84%) of the parvovirus B19 immunoglobulin M (IgM)-positive sera had a positive result for Epstein-Barr virus (EBV) IgM by Liaison testing, 61 (90%) had a positive result for herpes simplex virus (HSV) IgM, 20 (29%) samples were positive for cytomegalovirus IgM, and 15 (22%) had a positive result for Borrelia burgdorferi sensu lato IgM. As assay interference was suspected, sera were further investigated by using additional infectious-disease serology tests and by performing various interference elimination procedures. We could show that the EBV IgM and HSV IgM results were false positives due to aspecific IgM reactions with the solid phase. All samples were also analyzed by a modified Liaison EBV IgM assay, based on the addition of polyvinylpyrrolidone and polyvinyl alcohol to the dilution buffer, which partially eliminated this type of assay interference. Although the Liaison is a very convenient, automated immunoassay platform, this study demonstrates the potential for improvement of mainly the EBV IgM and HSV IgM tests.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116304      PMCID: PMC2650871          DOI: 10.1128/CVI.00380-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  13 in total

Review 1.  Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years.

Authors:  Ralf D Hess
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

2.  Serological diagnosis of infectious mononucleosis by chemiluminescent immunoassay using capsid antigen p18 of Epstein-Barr virus.

Authors:  Zhenru Feng; Zhiyan Li; Baohuan Sui; Guobing Xu; Tiean Xia
Journal:  Clin Chim Acta       Date:  2004-12-30       Impact factor: 3.786

3.  Suppression of non-specific binding in serological Luminex assays.

Authors:  Tim Waterboer; Peter Sehr; Michael Pawlita
Journal:  J Immunol Methods       Date:  2005-12-19       Impact factor: 2.303

4.  Prevention of assay interference in infectious-disease serology tests done on the liaison platform.

Authors:  Mario Berth; Eugene Bosmans
Journal:  Clin Vaccine Immunol       Date:  2008-03-12

5.  Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles.

Authors:  S Ratnam; G Tipples; C Head; M Fauvel; M Fearon; B J Ward
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  Resistance to nonspecific protein adsorption by poly(vinyl alcohol) thin films adsorbed to a poly(styrene) support matrix studied using surface plasmon resonance.

Authors:  D A Barrett; M S Hartshome; M A Hussain; P N Shaw; M C Davies
Journal:  Anal Chem       Date:  2001-11-01       Impact factor: 6.986

7.  Human parvovirus B19. Hard to differentiate from infectious mononucleosis.

Authors:  J W Jones; J V Pether; R W Frost
Journal:  BMJ       Date:  1994-02-26

8.  False positive rubeola IgM tests.

Authors:  S A Jenkerson; M Beller; J P Middaugh; D D Erdman
Journal:  N Engl J Med       Date:  1995-04-20       Impact factor: 91.245

9.  Polyvinylpyrrolidone as a blocking agent in immunochemical studies.

Authors:  J W Haycock
Journal:  Anal Biochem       Date:  1993-02-01       Impact factor: 3.365

10.  Enhanced enzyme-linked immunosorbent assay for detection of antibodies to virus-like particles of human papillomavirus.

Authors:  Yevgeniy Y Studentsov; Mark Schiffman; Howard D Strickler; Gloria Y F Ho; Yuk-Ying Susana Pang; John Schiller; Rolando Herrero; Robert D Burk
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

View more
  13 in total

1.  Performance of two commercially available automated immunoassays for the determination of Epstein-Barr virus serological status.

Authors:  J Lupo; R Germi; T Semenova; M Buisson; J M Seigneurin; P Morand
Journal:  Clin Vaccine Immunol       Date:  2012-04-25

2.  Analysis of viral testing in nonacetaminophen pediatric acute liver failure.

Authors:  Kathleen B Schwarz; Dominic Dell Olio; Steven J Lobritto; M James Lopez; Norberto Rodriguez-Baez; Nada A Yazigi; Steven H Belle; Song Zhang; Robert H Squires
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-11       Impact factor: 2.839

3.  Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.

Authors:  Isabel Corrales; Estela Giménez; David Navarro
Journal:  Clin Vaccine Immunol       Date:  2014-03-12

4.  Analytical issues possibly affecting the performance of commercial human cytomegalovirus IgG avidity assays.

Authors:  M Berth; L Grangeot-Keros; F Heskia; J-M Dugua; C Vauloup-Fellous
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-30       Impact factor: 3.267

5.  Comparison of three automated immunoassay methods for the determination of Epstein-Barr virus-specific immunoglobulin M.

Authors:  Mario Berth; Eugene Bosmans
Journal:  Clin Vaccine Immunol       Date:  2010-02-10

6.  Acute parvovirus B19 infection causes nonspecificity frequently in Borrelia and less often in Salmonella and Campylobacter serology, posing a problem in diagnosis of infectious arthropathy.

Authors:  Tamara Tuuminen; Klaus Hedman; Maria Söderlund-Venermo; Ilkka Seppälä
Journal:  Clin Vaccine Immunol       Date:  2010-11-24

7.  Occurrence of immunoglobulin M antibodies against several bacterial and viral pathogens in acute hantavirus infection.

Authors:  Nele Wellinghausen; Andrea Goetz; Ursula Weber
Journal:  Clin Vaccine Immunol       Date:  2012-07-11

8.  Performance of the Epstein-Barr virus and herpes simplex virus immunoglobulin m assays on the liaison platform with sera from patients displaying acute parvovirus B19 infection.

Authors:  Elisa Costa; Nuria Tormo; María Angeles Clari; Dayana Bravo; Beatriz Muñoz-Cobo; David Navarro
Journal:  Clin Vaccine Immunol       Date:  2009-07-01

9.  Evaluation of a standardised real-time PCR based DNA-detection method (Realstar®) in whole blood for the diagnosis of primary human cytomegalovirus (CMV) infections in immunocompetent patients.

Authors:  M Berth; I Benoy; N Christensen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-10       Impact factor: 3.267

10.  Performance of the architect EBV antibody panel for determination of Epstein-Barr virus infection stage in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis.

Authors:  Alvaro Guerrero-Ramos; Mauli Patel; Kinjal Kadakia; Tanzina Haque
Journal:  Clin Vaccine Immunol       Date:  2014-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.